STTKShattuck Labs, Inc.
$5.66+131% 1Y
$5.66
$1.7752 weeks$8.06
STTK in its own filings
Nothing in STTK's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
105
Events found in the filings · across 410 filings · the record starts in 2020
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 11, 2026
Most recent filing · Form 8-K
- Record starts
- Sep 3, 2020
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- SEC comment-letter activity17 occurrences
- 2026-01-16
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jun 11, 2026Underwritten Public Offering On June 9, 2026, Shattuck Labs, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with Leerink Partners LLC, J.P. Morgan Securities LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co., as the representatives of the underwriters named therein (the …Material agreement entered · Form 8-K
- Jun 9, 2026Data Release On June 8, 2026, the Company released its presentation on data from its Phase 1 clinical trial of SL-325.Regulation FD disclosure · Form 8-K
- Jun 2, 2026At the Annual Meeting, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Equity Incentive Plan (as so amended, the “Plan”) to revise the calculation of the automatic annual increase in the number of shares of common stock available for issuance, increase the number of shares …Director or officer change · Form 8-K
- Feb 5, 2026On February 5, 2026, the Board of Directors (the “Board”) of Shattuck Labs, Inc. (the “Company”) determined that the 2026 annual meeting of stockholders (the “Annual Meeting”) will be held on Thursday, May 28, 2026.Other event · Form 8-K
- Jan 22, 2026On January 22, 2026, Shattuck Labs, Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with Leerink Partners LLC (the “Agent”), pursuant to which the Company may offer and sell from time to time shares of the Company’s common stock, $0.0001 par value per share (the “Shares”), through the Agent.Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…